BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
土曜日, 9 26

SELLAS Life Sciences Group Inc

SLSNASDAQ
Trade with Public
Trade with Public
$11.61
-0.37-3.09%
近くで: Sep 25, 5:00 PM EST
$11.60
-0.01-0.09%
時間外: 7:59 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

SELLAS Life Sciences Gr Earnings & Forecasts

SELLAS Life Sciences Gr (SLS) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

SELLAS Life Sciences Gr Guidance

Recent Earnings Results

MetricQ2 '26Q1 '26Q4 '25Q3 '25
Earnings Per Share (Non-GAAP)
Estimate$-0.04$-0.06$-0.06$-0.08
Actual$-0.05$-0.05$-0.05$-0.06
Surprise-25.0%+16.7%+16.7%+25.0%
Revenue
Estimate————
Actual$0$0$0$0
Surprise————
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
MetricQ3 '26EQ4 '26E
Earnings Per Share (Non-GAAP)
Consensus$-0.05$-0.05
Revenue
Consensus——
More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
SELLAS Life Sciences Gr Q2 EPS $(0.05) Misses $(0.04) Estimate

SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 25 percent. This is a 28.57 percent increase over losses of $(0.07) per share
Benzinga Newsdesk

PRO
SELLAS Life Sciences Gr Q1 EPS $(0.05) Beats $(0.06) Estimate

SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 28.57 percent increase over losses of $(0.07) per share
Benzinga Newsdesk

PRO
SELLAS Life Sciences Gr Q4 EPS $(0.05) Beats $(0.07) Estimate

SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 37.5 percent increase over losses of $(0.08) per share
Benzinga Newsdesk

PRO
SELLAS Life Sciences Gr Q3 EPS $(0.06) Beats $(0.09) Estimate

SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 29.41 percent. This is a 40 percent increase over losses of $(0.10) per share
Benzinga Newsdesk

PRO
SELLAS Life Sciences Gr Q2 EPS $(0.07) Beats $(0.08) Estimate

SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 15.66 percent. This is a 46.15 percent increase over losses of $(0.13) per share
Benzinga Newsdesk

PRO
SELLAS Life Sciences Gr Q1 EPS $(0.07) Beats $(0.10) Estimate

SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 30 percent. This is a 66.67 percent increase over losses of $(0.21) per share
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved